Australia's most trusted
source of pharma news
Wednesday, 17 September 2025
Posted 16 September 2025 AM
AstraZeneca has landed vaccine contracts with two states for a needle-free paediatric vaccine, strengthening its market in the Southern Hemisphere.
The Queensland State Government has announced a $5 million investment to buy FluMist, an influenza vaccine administered as a nasal spray, while the NSW State Government will also make FluMist available through general practitioners.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.